MIRA INFORM REPORT

 

 

Report No. :

305184

Report Date :

29.01.2015

 

 

IDENTIFICATION DETAILS

 

Name :

ALPHA-PHARMA HEALTHCARE INDIA PRIVATE LIMITED

 

 

Registered Office :

B - 205, Universal Business Park, Off Saki Vihar Road, Chandivali, Andheri (East), Mumbai - 400072, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

20.12.2005

 

 

Com. Reg. No.:

11-234083

 

 

Capital Investment / Paid-up Capital :

Rs.196.125 Millions

 

 

CIN No.:

[Company Identification No.]

U24231MH2005PTC234083

 

 

PAN No.:

[Permanent Account No.]

AAFCA6695R

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Trader of Pharmaceutical Products.

 

 

No. of Employees :

Not Available [We tried to confirm the number of employees but no one is ready to part any information from the company management]

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (29)

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

USD 786000

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having   moderate track record.

 

As per Registrar of companies the date of balance sheet i.e. financials filed is shown as 31st March, 2014 but the documents related to the financials for the year 2014 are not available from any sources.

 

As per available financial of 2013, Reserves of the company seems to be low.

 

However, trade relations are fair. Business is active. Payment terms are reported to be slow but correct.

 

The company can be considered for business dealings with some cautions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – September 30, 2014

 

Country Name

Previous Rating

(30.06.2014)

Current Rating

(30.09.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

NOT AVAILABLE

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

 

INFORMATION PARTED BY (GENERAL DETAILS)

 

Name :

Mr. Ravi

Designation :

Accountant

Contact No.:

91-22-42911000

Date :

28.01.2015

 

 

LOCATIONS

 

Registered Office :

B - 205, Universal Business Park, Off Saki Vihar Road, Chandivali, Andheri (East), Mumbai - 400072, Maharashtra, India

Tel. No.:

91-22-42911000

Mobile No.:

91-9769664422 (Mr. Rajeev Pithadia)

Fax No.:

91-22-42911001

E-Mail :

jsf@alpha-pharma.com

Website :

http://www.alpha-pharma.com

 

 

DIRECTORS

 

AS ON 30.09.2014

 

Name :

Mr. Jacob Sporon Fiedler

Designation :

Director

Address :

Livornovej 9, Copenhagen S, Denmark - 2300

Date of Birth :

22.08.1981

Date of Appointment :

20.12.2005

DIN No.:

01660842

Other Directorship :

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24231MH2005PTC234083

ALPHA-PHARMA HEALTHCARE INDIA PRIVATE LIMITED

Director

20/12/2005

20/12/2005

-

Active

NO

2

U51909DL2010FTC198694

MOIRAE GENERICS PRIVATE LIMITED

Director

04/02/2010

04/02/2010

-

Active

NO

3

U24232MH2011FTC241859

DUNE MEDICARE PRIVATE LIMITED

Director

23/05/2011

23/05/2011

-

Active

NO

4

U24297MH2013FTC239278

UNIGEN LIFE SCIENCES INDIA PRIVATE LIMITED

Director

04/01/2013

04/01/2013

-

Active

NO

5

U24232MH2012PTC232068

Coin Pharmaceuticals Private Limited

Director

19/08/2013

19/08/2013

-

Active

NO

6

U74999MH2014FTC252081

Alpha-Pharma Performance Nutrition Private Limited

Director

15/01/2014

15/01/2014

-

Active

NO

 

 

Name :

Sherly Justine

Designation :

Director

Address :

Flat No. H-401, 4th Floor, Yashparadise, Sector No.8-A, Airoli, Navi Mumbai – 400708, Maharashtra, India

Date of Birth/Age :

01.02.1969

Date of Appointment :

28.09.2011

DIN No.:

03477901

Other Directorship :

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24232MH2011FTC241859

DUNE MEDICARE PRIVATE LIMITED

Director

23/05/2011

23/05/2011

-

Active

NO

2

U24231MH2005PTC234083

ALPHA-PHARMA HEALTHCARE INDIA PRIVATE LIMITED

Director

28/09/2011

26/07/2011

-

Active

NO

3

U24297MH2013FTC239278

UNIGEN LIFE SCIENCES INDIA PRIVATE LIMITED

Director

04/01/2013

04/01/2013

-

Active

NO

4

U24232MH2012PTC232068

Coin Pharmaceuticals Private Limited

Director

07/01/2013

07/01/2013

-

Active

NO

5

U74999MH2014FTC252081

Alpha-Pharma Performance Nutrition Private Limited

Director

15/01/2014

15/01/2014

-

Active

NO

 

 

KEY EXECUTIVES

 

Name :

Deepika Jaiprakash Jaiswal

Designation :

Secretary

Address :

204, 2nd Floor, Vikas Apartments, Sainath Nagar, Vs Road, Virar (East), Thane – 401303, Maharashtra, India 

Date of Birth/Age :

21.05.1988

Date of Appointment :

15.06.2012

Date of Cessation :

09.12.2013

Pan No. : 

AKWPJ7095E

 

Name :

Jayesh Chandrakant Awati

Designation :

Secretary

Address :

Babaji Chwl, Ram Mandir, Veer Kotwal Chowk, Kala Talao, Kalyan (West), Thane – 421301, Maharashtra, India

Date of Birth/Age :

13.12.1988

Date of Appointment :

09.12.2013

Pan No. : 

AUDPA7536Q

 

Name :

Mr. Ravi

Designation :

Accountant

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 30.09.2014

 

Names of Shareholders

 

No. of Shares

Sporon-Fiedler Jacob, Denmark

 

49164

Alpha Pharma Group Limited, Seychelles

 

39769269

Total

 

39818433

 

 

 

AS ON 30.09.2014

 

Equity Share Break up (Percentage of Total Equity)

 

Category

Percentage

Bodies corporate

100.00

Total

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

Trader of Pharmaceutical Products.

 

 

Brand Names :

Not Divulged

 

 

Agencies Held :

Not Divulged

 

 

Exports :

Not Divulged

 

 

Imports :

Not Divulged

 

 

Terms :

 

Selling :

Cash and Cheque

 

 

Purchasing :

Cash and Cheque

 

PRODUCTION STATUS : NOT AVAILABLE

 

 

GENERAL INFORMATION

 

Suppliers :

Not Divulged

 

 

Customers :

Not Divulged

 

 

No. of Employees :

Not Available [We tried to confirm the number of employees but no one is ready to part any information from the company management]

 

 

Bankers :

  • HDFC Bank Limited
  • Standard Chartered Bank Limited
  • ING Vysya Bank Limited

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Borkar and Shenoy

Chartered Accountants

Address :

8, National CHS Limited, Behind Bus Depot, Sector – 3, Airoli, Navi Mumbai - 400708, Maharashtra, India 

PAN.:

AADFB6915E

 

 

Holding Company :

Alpha-Pharma Group

Limited

 

 

Enterprises which are owned, or have significant influence of or are partners with Key management personnel and their relatives :

  • Moirae Generics Private Limited [MGPL] U51909DL2010FTC198694
  • Dune Medicare Private Limited [DMPL] U24232MH2011FTC241859

 

 

 

CAPITAL STRUCTURE

 

AFTER 30.09.2014

 

 Authorised Capital : Rs.600.000 Millions

 

Issued, Subscribed & Paid-up Capital : Rs.496.363 Millions

 

AS ON 30.09.2014

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

50000000

Equity Shares

Rs.10/- each

Rs.500.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

39818433

Equity Shares

Rs.10/- each

Rs.398.184 Millions

 

 

 

 

 

 

AS ON 31.03.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

25000000

Equity Shares

Rs.10/- each

Rs.250.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

1,96,12,523

Equity Shares

Rs.10/- each

Rs.196.125 Millions

 

 

 

 

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

31.03.2013

31.03.2012

31.03.2011

 

 

 

 

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

196.125

65.681

30.092

(b) Reserves & Surplus

22.835

15.524

-8.277

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

55.847

18.627

4.649

Total Shareholders’ Funds (1) + (2)

274.807

99.832

26.464

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

0.000

0.000

0.000

(b) Deferred tax liabilities (Net)

0.000

0.000

0.721

(c) Other long term liabilities

0.317

2.309

4.327

(d) long-term provisions

8.460

5.660

0.040

Total Non-current Liabilities (3)

8.777

7.969

5.088

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

0.000

0.000

0.000

(b) Trade payables

27.886

13.680

5.398

(c) Other current liabilities

17.704

7.086

8.232

(d) Short-term provisions

1.203

0.914

0.856

Total Current Liabilities (4)

46.793

21.680

14.486

 

 

 

 

TOTAL

330.377

129.481

46.038

 

 

 

 

II.          ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

43.456

39.973

30.166

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Capital work-in-progress

115.013

0.000

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

4.090

4.547

0.000

(d)  Long-term Loan and Advances

30.005

8.531

2.347

(e) Other Non-current assets

3.099

0.971

5.201

Total Non-Current Assets

195.663

54.022

37.714

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

38.529

18.021

4.994

(c) Trade receivables

64.397

28.469

0.325

(d) Cash and cash equivalents

31.469

26.657

2.787

(e) Short-term loans and advances

0.304

2.312

0.218

(f) Other current assets

0.015

0.000

0.000

Total Current Assets

134.714

75.459

8.324

 

 

 

 

TOTAL

330.377

129.481

46.038

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2013

31.03.2012

31.03.2011

 

SALES

 

 

 

 

 

Income

227.163

140.950

49.520

 

 

Other Income

 

 

 

 

 

TOTAL                                    

227.163

140.950

49.520

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Office Expenses

 

 

 

 

 

Administrative Expenses

213.587

114.153

46.136

 

 

Advertising Expenses

 

 

 

 

 

TOTAL                        

213.587

114.153

46.136

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

13.576

26.797

3.384

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION        

3.008

2.643

2.420

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX

10.568

24.154

0.964

 

 

 

 

 

Less

TAX                             

3.258

0.353

0.436

 

 

 

 

 

 

PROFIT / (LOSS) AFTER TAX

7.310

23.801

0.528

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

15.525

(8.276)

(8.804)

 

 

 

 

 

 

BALANCE / (LOSS) CARRIED TO THE B/S

22.835

15.525

(8.276)

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Earnings

NA

126.995

45.657

 

TOTAL EARNINGS

NA

126.995

45.657

 

 

 

 

 

 

Earnings / (LOSS) Per Share (Rs.)

0.37

2.88

(0.18)

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2013

31.03.2012

31.03.2011

Net Profit Margin
(PAT / Sales)

(%)

3.22

16.89

1.07

 

 

 

 

 

Operating Profit Margin
(PBIDT/Sales)

 

5.98

19.01

6.83

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

5.00

19.33

2.09

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.04

0.24

0.04

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

0.00

0.00

0.00

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

2.88

3.48

0.57

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particular

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Share Capital

30.092

65.681

196.125

Reserves & Surplus

-8.277

15.524

22.835

 Share Application money pending allotment

4.649

18.627

55.847

Net worth

26.464

99.832

274.807

 

 

 

 

long-term borrowings

0.000

0.000

0.000

Short term borrowings

0.000

0.000

0.000

Total borrowings

0.000

0.000

0.000

Debt/Equity ratio

0.000

0.000

0.000

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

49.520

140.950

227.163

 

 

184.632

61.166

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

49.520

140.950

227.163

Profit

0.528

23.801

7.310

 

1.07%

16.89%

3.22%

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

----------------------

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

Yes

20]

Export / Import details (if applicable)

No

21]

Market information

----------------------

22]

Litigations that the firm / promoter involved in

----------------------

23]

Banking Details

Yes

24]

Banking facility details

No

25]

Conduct of the banking account

----------------------

26]

Buyer visit details

----------------------

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

NOTE:

 

The registered office of the company has been shifted from C-68, Neetri Bagh, 2nd Floor, New Delhi-49, India to present address w.e.f. 30.07.2012.

 

INDEX OF CHARGES : NO CHARGES EXIST FOR COMPANY

 

FIXED ASSETS

 

  • Buildings
  • Plant and equipment
  • Furniture and fixtures
  • Vehicles
  • Office equipment
  • Computer equipments
  • Other equipments

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                                       None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.61.41

UK Pound

1

Rs.93.18

Euro

1

Rs.69.82

 

 

INFORMATION DETAILS

 

Information Gathered by :

GYT

 

 

Analysis Done by :

RAS

 

 

Report Prepared by :

SNT

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

4

PAID-UP CAPITAL

1~10

4

OPERATING SCALE

1~10

4

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

4

--PROFITABILIRY

1~10

2

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

2

--CREDIT LINES

1~10

3

--MARGINS

-5~5

---

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

29

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.